Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes

Molecular Immunology

Volumn 35, Issue 8, 1998, Pages 445-458

  Swanson, Bradley J ^a   Jäck, Hans Martin ^a   Lyons, Gary E ^a  

^a NONE

Author keywords

Electrophoretic mobility shift assay (EMSA); Immunoblot; In situ hybridization; Lymphocytes; MEF2; Transcription factors

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN; MYOCYTE ENHANCER FACTOR 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; DNA BINDING; ELECTROPHORETIC MOBILITY; EMBRYO; FETUS; FETUS LIVER; IN SITU HYBRIDIZATION; LYMPH NODE; LYMPHOID TISSUE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; BINDING SITES; CELLS, CULTURED; CREATINE KINASE; DNA-BINDING PROTEINS; LYMPHOID TISSUE; MYOGENIC REGULATORY FACTORS; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 0345647074     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(98)00058-3     Document Type: Article

References (47)

1. Bain, G., Maandag, B.C., Izon, D.J., Amsen, D., Kruisbeek, A.M., Weintraub, B.C., Krop, I., Schlissel, M.S., Feeney, A.J., van Roon, M., van der Valk, M., te Riele, H.P.J., Berns, A., Murre, C., 1994. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79, 885-892.
2. Baker, S.J., Reddy, E.P., 1995. B cell differentiation: Role of E2A and Pax5/BSAP transcription factors. Oncogene 11, 413-426.
3. Barbara, E., Mishell, B. and Shiigi, S.M., 1980. Lysis of red blood cells with TRIS-buffered ammonium chloride. In Barbara, E., Mishell, B. and Shiigi, S.M. (Eds.), Selected Methods in Cellular Immunology. WH Freeman and Company, New York, p. 227.
4. Black, B.L., Lu, J., Olson, E.N., 1997. The MEF2A 3′ untranslated region functions as a cis-acting translational repressor. Mol. Cell. Biol. 17, 2756-2763.
5. Bornemann, K.D., Brewer, J.W., Beck-Engeser, G.B., Corley, R.B., Haas, I.G., Jack, H.M., 1995. Roles of heavy and light chains in IgM polymerization. Proc. Natl. Acad. Sci. USA 92, 4912-4916.
6. Clevers, H.C., Grosschedl, R., 1996. Transcriptional control of lymphoid development: Lessons from gene targeting. Immunol. Today 17, 336-343.
7. Cserjesi, P., Olson, E.N., 1991. Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products. Mol. Cell. Biol. 11, 4854-4862.
8. Davidson, W.F., Fredrickson, T.N., Rudikoff, E.K., Coffman, R.L., Hartley, J.W., Morse, H.C.d., 1984. A unique series of lymphomas related to the Ly-1+lineage of B lymphocyte differentiation. J. Immunol. 133, 744-753.
9. Dorshkind, K., 1994. Transcriptional control points during lymphopoiesis. Cell 79, 751-753.
10. Edmondson, D.G., Lyons, G.E., Martin, J.F., Olson, E.N., 1994. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development 120, 1251-1263.
11. Firulli, A.B., Miano, J.M., Bi, W., Johnson, A.D., Casscells, W., Olson, E.N., Schwarz, J.J., 1996. Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells. Association with the activated phenotype. Circ. Res. 78, 196-204.
12. Gillies, S.D., Morrison, S.L., Oi, V.T., Tonegawa, S., 1983. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell 33, 717-728.
13. Gossett, L.A., Kelvin, D.J., Sternberg, E.A., Olson, E.N., 1989. A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol. Cell. Biol. 9, 5022-5033.
14. Graves, J.D., Draves, K.E., Craxton, A., Saklatvala, J., Krebs, E.G., Clark, E.A., 1996. Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes. Proc. Natl. Acad. Sci. USA 93, 13814-13818.
15. Gutman, G.A., Warner, N.L., Harris, A.W., 1981. Immunoglobulin production by murine B-lymphoma cells. Clin. Immunol. Immunopathol. 18, 230-244.
16. Han, T.H., Prywes, R., 1995. Regulatory role of MEF2D in serum induction of the c-jun promoter. Mol. Cell. Biol. 15, 2907-2915.
17. Horibata, K., Harris, A.W., 1970. Mouse myelomas and lymphomas in culture. Exp. Cell. Res. 60, 61-77.
18. Han, J., Jiang, Y., Li, Z., Kravchenko, V.V., Ulevitch, R.J., 1997. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386, 296-299.
19. Jack, H.M., Beck-Engeser, G., Lee, G., Wofsy, D., Wabl, M., 1992. Tumorigenesis mediated by an antigen receptor. Proc. Natl. Acad. Sci. USA 89, 8482-8486.
20. Kaushal, S., Schneider, J.W., Nadal-Ginard, B., Mahdavi, V., 1994. Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with MyoD. Science 266, 1236-1240.
21. Keyna, U., Beck-Engeser, G.B., Jongstra, J., Applequist, S.E., Jack, H.M., 1995. Surrogate light chain-dependent selection of Ig heavy chain V regions. J. Immunol. 155, 5536-5542.
22. Kitamura, D., Kudo, A., Schaal, S., Muller, W., Melchers, F., Rajewsky, K., 1992. A critical role of lambda 5 protein in B cell development. Cell 69, 823-831.
23. Leifer, D., Golden, J., Kowall, N.W., 1994. Myocyte-specific enhancer binding factor 2C expression in human brain development. Neuroscience 63, 1067-1079.
24. Lin, H., Grosschedl, R., 1995. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376, 263-267.
25. Lin, Q., Schwarz, J., Bucana, C., Olson, E.N., 1997. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276, 1404-1407.
26. Liu, S., Liu, P., Borras, A., Chatila, T., Speck, S.H., 1997. Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO J. 16, 143-153.
27. Lyons, G.E., Micales, B.K., Schwarz, J., Martin, J.F., Olson, E.N., 1995. Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J. Neurosci. 15, 5727-5738.
28. Manz, J., Denis, K., Witte, O., Brinster, R., Storb, U., 1988. Feedback inhibition of immunoglobulin gene rearrangement by membrane mu, but not by secreted mu heavy chains. J. Exp. Med. 168, 1363-1381.
29. Martin, J.F., Schwarz, J.J., Olson, E.N., 1993. Myocyte enhancer factor (MEF) 2C: A tissue-restricted member of the MEF-2 family of transcription factors. Proc. Natl. Acad. Sci. USA 90, 5282-5286.
30. Molkentin, J.D., Black, B.L., Martin, J.F., Olson, E.N., 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83, 1125-1136.
31. Molkentin, J.D., Firulli, A.B., Black, B.L., Martin, J.F., Hustad, C.M., Copeland, N., Jenkins, N., Lyons, G., Olson, E.N., 1996. MEF2B is a potent transactivator expressed in early myogenic lineages. Mol. Cell. Biol. 16, 3814-3824.
32. Molkentin, J.D., Li, L., Olson, E.N., 1996. Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity. J. Biol. Chem. 271, 17199-17204.
33. Murphy, K.M., Heimberger, A.B., Loh, D.Y., 1990. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCR1o thymocytes in vivo. Science 250, 1720-1723.
34. Olson, E.N., Perry, M., Schulz, R.A., 1995. Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors. Dev. Biol. 172, 2-14.
35. Ornatsky, O.I., Andreucci, J.J., McDermott, J.C., 1997. A dominant-negative form of transcription factor MEF2 inhibits myogenesis. J. Biol. Chem. 272, 33271-33278.
36. Pan, H., Griep, A.E., 1994. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor suppressor gene function in development. Gen. Dev. 8, 1285-1299.
37. Rudin, C.M., Storb, U., 1992. Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factors. Mol. Cell. Biol. 12, 309-320.
38. Schreiber, E., Matthias, P., Muller, M.M., Schaffner, W., 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17, 6419.
39. Shevach, E.M., Stobo, J.D., Green, I., 1972. Immunoglobulin and theta-bearing murine leukemias and lymphomas. J. Immunol. 108, 1146-1151.
40. Storb, U., Kruisbeek, A.M., 1996. Lymphocyte development. Curr. Opin. Immunol. 8, 155-159.
41. Sutherland, C.L., Heath, A.W., Pelech, S.L., Young, P.R., Gold, M.R., 1996. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J. Immunol. 157, 3381-3390.
42. Suzuki, E., Guo, K., Kolman, M., Yu, Y.T., Walsh, K., 1995. Serum induction of MEF2/RSRF expression in vascular myocytes is mediated at the level of translation. Mol. Cell. Biol. 15, 3415-3423.
43. Taylor, J.M., Dupont-Versteegden, E.E., Davies, J.D., Hassell, J.A., Houle, J.D., Gurley, C.M., Peterson, C.A., 1997. A role for the ETS domain transcription factor PEA3 in myogenic differentiation. Mol. Cell. Biol. 17, 5550-5558.
44. Urbanek, P., Wang, Z.Q., Fetka, I., Wagner, E.F., Busslinger, M., 1994. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79, 901-912.
45. Warner, N.L., Daley, M.J., Richey, J., Spellman, C., 1979. Flow cytometry analysis of murine B cell lymphoma differentiation. Immunol. Rev. 48, 197-243.
46. Woronicz, J.D., Lina, A., Calnan, B.J., Szychowski, S., Cheng, L., Winoto, A., 1995. Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis. Mol. Cell. Biol. 15, 6364-6376.
47. Zhuang, Y., Soriano, P., Weintraub, H., 1994. The helix-loop-helix gene E2A is required for B cell formation. Cell 79, 875-884.